Literature DB >> 7944634

Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.

Y Kawaguchi1, K Suzuki, M Hara, T Hidaka, T Ishizuka, M Kawagoe, H Nakamura.   

Abstract

OBJECTIVES: To determine whether fibroblasts from patients with systemic sclerosis (SSc) produce excessive amounts of endothelin-1 (ET-1), which is recognised as having vasoconstrictive properties and as having a potent mitogenic effect on fibroblasts.
METHODS: Dermal fibroblasts were removed from 11 patients with SSc and from five normal controls (NC). The assay of ET-1 protein was measured by an ELISA that used two anti-ET-1 antibodies. The gene expression of prepro ET-1 mRNA was evaluated by a reverse-transcriptase polymerase chain reaction (RT-PCR) method.
RESULTS: Levels of ET-1 protein were significantly higher in SSc fibroblast cultures than in those of normal fibroblasts (p < 0.01). The expression of prepro ET-1 mRNA was also higher in SSc fibroblasts than in normal fibroblasts. The addition of interleukin-1 beta (IL-1 beta) increased the production of ET-1 by fibroblasts.
CONCLUSION: The findings indicate that the overproduction of ET-1 is a novel abnormal function in SSc fibroblasts, and that ET-1 induced by fibroblasts may play a role in the fibrosis and Raynaud's phenomenon of SSc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944634      PMCID: PMC1005389          DOI: 10.1136/ard.53.8.506

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

Authors:  M Ihara; K Noguchi; T Saeki; T Fukuroda; S Tsuchida; S Kimura; T Fukami; K Ishikawa; M Nishikibe; M Yano
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  Endothelin induces potent microvascular constriction.

Authors:  S D Brain; J R Tippins; T J Williams
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.

Authors:  S A Jimenez; G Feldman; R I Bashey; R Bienkowski; J Rosenbloom
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

5.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

Authors:  E C LeRoy
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

6.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.

Authors:  M Clozel; V Breu; K Burri; J M Cassal; W Fischli; G A Gray; G Hirth; B M Löffler; M Müller; W Neidhart
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

7.  Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells.

Authors:  T Horio; M Kohno; K Yasunari; K Murakawa; K Yokokawa; M Ikeda; T Fukui; T Takeda
Journal:  Atherosclerosis       Date:  1993-07       Impact factor: 5.162

8.  Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis.

Authors:  Y Kawaguchi; M Harigai; A Kitani; K Suzuki; M Kawakami; T Ishizuka; T Hidaka; M Hara; M Kawagoe; H Nakamura
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

9.  Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.

Authors:  C A Feghali; K L Bost; D W Boulware; L S Levy
Journal:  J Rheumatol       Date:  1992-08       Impact factor: 4.666

10.  Cyclical strain increases endothelin-1 secretion and gene expression in human endothelial cells.

Authors:  D L Wang; C C Tang; B S Wung; H H Chen; M S Hung; J J Wang
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

View more
  22 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

3.  Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.

Authors:  Xu Shi-Wen; Fernando Rodríguez-Pascual; Santiago Lamas; Alan Holmes; Sarah Howat; Jeremy D Pearson; Michael R Dashwood; Roland M du Bois; Christopher P Denton; Carol M Black; David J Abraham; Andrew Leask
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 4.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

5.  dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.

Authors:  Giuseppina Farina; Michael York; Cindy Collins; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

6.  Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Edoardo Rosato; Felice Salsano; Giovanni Spera
Journal:  Int J Rheumatol       Date:  2010-10-05

Review 7.  Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.

Authors:  Pei-Suen Tsou; Andrew J Haak; Dinesh Khanna; Richard R Neubig
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

8.  Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.

Authors:  K Takagi; Y Kawaguchi; M Hara; T Sugiura; M Harigai; N Kamatani
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.

Authors:  Xu Shi-Wen; Yunliang Chen; Christopher P Denton; Mark Eastwood; Elisabetta A Renzoni; George Bou-Gharios; Jeremy D Pearson; Michael Dashwood; Roland M du Bois; Carol M Black; Andrew Leask; David J Abraham
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

10.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.